852
Views
14
CrossRef citations to date
0
Altmetric
Infectious Disease

Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies

, , , &
Pages 473-479 | Received 12 Jul 2015, Accepted 30 Dec 2015, Published online: 30 Mar 2016

References

  • Chosidow O. Scabies and pediculosis. Lancet. 2000;355:819–21.
  • Andrews RM, McCarthy J, Carapetis JR, Currie BJ. Skin disorders, including pyoderma, scabies, and Tinea infections. Pediatr Clin North Am. 2009;56:1421–40.
  • Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006;354:1718–27.
  • Walton SF, Holt DC, Currie BJ, Kemp DJ. Scabies: new future for a neglected disease. Adv Parasitol. 2004;57:309–76.
  • Currie BJ, McCarthy JS. Permethrin and Ivermectin for scabies. N Engl J Med. 2010;362:717–25.
  • Pasay C, Walton S, Fischer K, et al. PCR-based assay to survey for knockdown resistance to pyrethriod acaricides in human scabies mites (sarcoptes scabiei var. hominis). Am J Trop Med Hyg. 2006;74:649–57.
  • Ohtaki N. Scabies – diagnosis, treatment, and prevention. Anitbiot Chemother. 2003;19:70–4.
  • Dilawar S, Rizvi A, Iftikhar N, Batool F. Effectiveness of oral ivermectin for eradicating infesting mites in patients of scabies. J Pak Assoc Dermatol. 2011;21:87–92.
  • McCarthy JS, Kemp DJ, Walton SF, Curri BJ. Scabies: more than just an irritation. Postgrad Med J. 2004;80:382–7.
  • Monsel G, Chosidow O. Management of scabies. Skin Therapy Lett. 2012;17:1–4.
  • Walker GJ, Johnston PW. Interventions for treating scabies. Cochrane Database Syst Rev. 2000;3:CD000320. PMID:10908470.
  • Ly F, Caumes E, Ndaw CAT, et al. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ. 2009;87:424–30.
  • Mahé A, Faye O, N’Diaye HT, et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2005;99:39–47.
  • Bachewar NP, Thawani VR, Mali SN, et al. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian J Pharmacol. 2009;41:9–14.
  • Heukelbach J, Feldmeier H. Scabies. Lancet. 2006;367:1767–74.
  • Elgart ML. Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies. Exp Opin Pharmacother. 2003;4:1521–4.
  • Amerio P, Capizzi R, Milani M. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigatorblinded, comparative trial vs. permethrin cream. Eur J Dermatol. 2003;13:69–71.
  • Paasch U, Haustein UF. Treatment of endemic scabies with allethrin, permethrin and ivermectin. Hautarzt. 2001;52:31–7.
  • Strong M, Johnstone PW. Interventions for treating scabies (update). Cochrane Database Syst Rev. 207;18:CD000320.
  • Khan I, Yasmin R. Ivermectin in the treatment of scabies. J Pak Assoc Dermatol. 2007;17:78–83.
  • Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol. 2000;42:236–40.
  • Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprol. 2011;77:581–6.
  • Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol. 2012;39:545–7.
  • Iqbal J, Shahid M, Mann MA. Scabies; oral ivermectin as the treatment. Professional Med J. 2009;16:263–9.
  • Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol. 2003;17:217–25.
  • Glaziou P, Cartel JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol. 1993;44:331–2.
  • Bates P, Rankin M, Clifford D, Stubbings L. Shower dipping in diazinon or cypermethrin dipwash to control ovine psoroptic mange (sheep scab). Vet Rec. 2005;156:655.
  • Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy. 2005;25:448–50.
  • Pourhasan A, Goldust M, Rezaee E. Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream. Ann Parasitol. 2013;59:143–7.
  • Chhaiya SB, Patel VJ, Dave JN, et al. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol. 2012;78:605–10.
  • Sharquie KE, Al-Rawi JR, Noaimi AA, Al-Hassany HM. Treatment of scabies using 8% and 10% topical sulfur ointment in different regimens of application. J Drugs Dermatol. 2012;11:357–64.
  • Mounsey KE, McCarthy JS. Treatment and control of scabies. Curr Opin Infect Dis. 2013;26:133–9.
  • Hengge UR, Currie BJ, Jager G, et al. Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis. 2006;6:769–79.
  • Steer AC, Kearns T, Andrews RM, et al. Ivermectin worthy of further investigation. Bull World Health Organ. 2009;87:A.
  • Lawrence G, Leafasia J, Sheridan J, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42.
  • Abedin S, Narang M, Gandhi V, Narang S. Efficacy of permethrin cream and oral ivermectin in treatment of scabies. Indian J Pediatr. 2007;74:915–16.
  • Dunne CL, Malone CJ, Whitworth JA. A field study of the effects of ivermectin on ectoparasites of man. Trans R Soc Trop Med Hyg. 1991;85:550–1.
  • Kar SK, Mania J, Patnaik S. The use of ivermectin for scabies. Natl Med J India. 1994;7:15–16.
  • Ribeiro Fde A, Taciro E, Guerra MR, Eckley CA. Oral ivermectin for the treatment and prophylaxis of scabies in prison. J Dermatolog Treat. 2005;16:138–41.
  • Haas N, Lindemann U, Frank K, et al. Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies. Arch Dermatol. 2002;138:1618–19.
  • Boussinesq M. Ivermectin. Med Trop (Mars). 2005;65:69–79.
  • Speare R, Durrheim D. Mass treatment with ivermectin: an underutilized public health strategy. Bull World Health Organ. 2004;82:562.
  • Heukelbach J, Wilcke T, Winter B, et al. Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasites. Arzneimittelforschung. 2004;54:416–21.
  • Nnoruka EN. Successful treatment of scabies with oral ivermectin in Nigeria. Trop Doct. 2001;31:15–18.
  • Sule HM, Thacher TD. Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients. Am J Trop Med Hyg. 2007;76:392–5.
  • Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20:268–79.
  • Dahl MV. The immunology of scabies. Ann Allergy. 1983;51:560–6.
  • Burn DA. Diseases caused by arthropods and other noxious animals. In Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology. 8th ed. London: Wiley-Blackwell, 2010. p 38.36–45.
  • Sivasubramanian G, Siddiqui MF, Tangella KR. Scabies crustosa following corticosteroid therapy in an elderly patient. Am J Med Sci. 2012;343:248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.